Most adults with active ankylosing spondylitis or non-radiographic axial spondyloarthritis who achieved low or no disease activity after four months on the recently approved Bimzelx (bimekizumab-bkzx) maintained their clinical response over at least two years. Two-year data from the Phase 3 clinical trials BE MOBILE 1 (NCT03928704)…
Read more
It’s been a while since my last column, and I apologize for that. I’ll try to unpack several of the challenges that have come up for me in recent months. While they’re not all directly linked to ankylosing spondylitis (AS), I believe that many of you will relate to…
Ankylosing spondylitis (AS) is a type of arthritis that mainly affects the joints of the spine. Inflammation of the spaces between the vertebrae causes back pain and stiffness.
There is no single specific test to diagnose AS, and many of the symptoms (such as back pain) also can be caused by other conditions. A diagnosis often involves checking for common hallmarks of AS.
Patients’ symptoms usually progress gradually over time. They may be erratic because the type and severity of the symptoms can improve, worsen, or completely stop for periods of time.
Get regular updates to your inbox.
